Memphasys Limited focuses on reproductive biotechnology and proprietary cell separation techniques. The Company develops novel medical devices, diagnostics, and media with application to assisted reproduction technologies, including IVF in humans and artificial insemination in animals.

Notification of cessation of securities - MEM

Order for Felix System to Evaluate Suitability in UAE

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Memphasys (MEM AU)

Notification of cessation of securities - MEM

Order for Felix System to Evaluate Suitability in UAE

RoXsta System's Potential in Cattle Breeding being Explored

Second Supplementary Prospectus

Extension of convertible note

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)